Here are four things to know.
1. TeamHealth said AmSurg’s cash-and-stock offer still undervalued the company, leading AmSurg to retract the offer, according to the report.
2. If the transaction had taken place, AmSurg and TeamHealth would have each owned 50 percent of the combined entity.
3. Both companies recently closed acquisitions of their own. TeamHealth acquired IPC Healthcare for $1.6 billion, and AmSurg acquired Sheridan Healthcare for $2.3 billion.
4. The additional $4 per share in the latest, and now defunct, offer from AmSurg was aimed to compensate for any potential penalties from financing the IPC Healthcare transaction, according to the report.
More articles on transactions and valuation issues:
11 new outpatient surgery centers in October
4 things to know about ASC benchmarking, transactions and valuation
Should you sell your ASC?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.